Status:
UNKNOWN
Pregnancy Rates in IVF After Ovulation Triggering With Recombinant or Urinary Human Chorionic Gonadotrophin (HCG)
Lead Sponsor:
Universitair Ziekenhuis Brussel
Collaborating Sponsors:
Merck Serono International SA
Conditions:
Embryonic Development
Pregnancy
Eligibility:
FEMALE
20-36 years
Phase:
PHASE3
Brief Summary
To access whether the ovulation triggering with rec-HCG instead urinary-HCG has any impact on the blastulation rate and pregnancy rate of patients undergoing IVF treatment
Eligibility Criteria
Inclusion
- FSH\<12,
- normal sperm,less than 36y,
- single blastocyst transfer
Exclusion
- endometriosis stage 3\&4,
- pco
Key Trial Info
Start Date :
August 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2010
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT00954265
Start Date
August 1 2005
End Date
September 1 2010
Last Update
December 24 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre for Reproductive Medicine, UZ Brussel
Brussels, Jette, Belgium, 1090